Drug intelligence / Profile preview

shengjingsan

Development stage: Unknown
Lead developer: Peking University
Administration: Oral

Overview

Shengjingsan is a Traditional Chinese Medicine (TCM) herbal formula used for the treatment of male infertility, specifically asthenospermia (low sperm motility). Clinical research indicates that Shengjingsan promotes sperm motility by activating the sperm-specific cation channel (CatSper), which is essential for calcium influx and sperm hyperactivation. The formula is typically administered orally as a powder or in capsule form and has been studied in clinical trials conducted by institutions such as Peking University and Shandong University of Traditional Chinese Medicine.

Other names: Sheng Jing San生精散

Targets

CatSper

Beyond the preview

Go deeper on shengjingsan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on shengjingsan.

Explore the full profile